Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study.

Donovan J, Hamdy F, Neal D, Peters T, Oliver S, Brindle L, Jewell D, Powell P, Gillatt D, Dedman D, Mills N, Smith M, Noble S, Lane A; ProtecT Study Group.

Health Technol Assess. 2003;7(14):1-88. No abstract available.

2.

Diagnosis and treatment of patients with prostate cancer: the nurse's role.

Turner B.

Nurs Stand. 2007 Jun 6-12;21(39):48-56; quiz 58. Review.

PMID:
17569378
3.

Prostate cancer overview. Part 1: non-metastatic disease.

Drudge-Coates L, Turner B.

Br J Nurs. 2012 May 10-23;21(9):S23-8. Review.

PMID:
22690411
4.

Advances in prostate cancer.

Small EJ.

Curr Opin Oncol. 1999 May;11(3):226-35. Review.

PMID:
10328599
5.

A guideline to clinical utility of prostate specific antigen.

Farhat WA, Habbal AA, Khauli RB.

Saudi Med J. 2000 Mar;21(3):223-7. Review.

PMID:
11533789
6.

Prostate cancer: to screen or not to screen?

Neal DE, Donovan JL.

Lancet Oncol. 2000 Sep;1(1):17-24. Review.

PMID:
11905682
7.

Prostate cancer--what should be studied?

James ND, Glaholm J.

Eur J Cancer. 1995 Sep;31A(10):1565-6. Review. No abstract available.

PMID:
7488401
8.

[Treatment of clinically localized prostate cancer. Part I--observation or treatment?].

Szelachowska J, Kornafel J, Gisterek I.

Pol Merkur Lekarski. 2006 Dec;21(126):594-7. Review. Polish.

PMID:
17405305
10.

Early prostate cancer diagnosis and therapy.

Glodé LM.

Adv Intern Med. 2000;45:41-64. Review. No abstract available.

PMID:
10635045
11.

A rational approach to prostate cancer.

Kirk D.

Practitioner. 2000 Sep;244(1614):750, 754-6, 758 passim. Review. No abstract available.

PMID:
11048371
12.

The prostate specific antigen. Its use as a tumor marker for prostate cancer.

Kantoff PW, Talcott JA.

Hematol Oncol Clin North Am. 1994 Jun;8(3):555-72. Review.

PMID:
8707772
13.

Active surveillance for favorable-risk prostate cancer: what are the results and how safe is it?

Klotz L.

Curr Urol Rep. 2007 Sep;8(5):341-4. Review. No abstract available.

PMID:
17880830
14.

Prostate cancer in older men.

Calabrese DA.

Urol Nurs. 2004 Aug;24(4):258-64, 268; quiz 269. Review.

PMID:
15446376
15.

Prostatic cancer.

Olsson C.

Kidney Int. 1993 Apr;43(4):955-65. Review. No abstract available.

16.

[Clinics in prostate cancer].

Sugimura Y.

Rinsho Byori. 2004 Jul;52(7):604-10. Review. Japanese.

PMID:
15344560
17.

Prostate cancer. Primary care providers play critical role.

Holden J, Emery CB.

Adv Nurse Pract. 2004 Apr;12(4):28-35; quiz 36. Review. No abstract available.

PMID:
15101132
18.

Methodology of patient care for elevated PSA after prostate cancer treatment: A primary care perspective.

Baum N, Levy J.

Postgrad Med. 2015 Aug;127(6):654-9. doi: 10.1080/00325481.2015.1059248. Epub 2015 Jun 29. Review.

PMID:
26118565
19.

Screening for prostate cancer with prostate-specific antigen. An examination of the evidence.

Woolf SH.

N Engl J Med. 1995 Nov 23;333(21):1401-5. Review. No abstract available.

PMID:
7477122
20.

Early diagnosis and treatment of prostate cancer.

Eastham JA, Scardino PT.

Dis Mon. 2001 Sep;47(9):421-59. Review. No abstract available.

PMID:
11584249

Supplemental Content

Support Center